Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALTEROLA BIOTECH, INC.

(ABTI)
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

ALTEROLA BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)

06/21/2021 | 02:22pm EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 21, 2021, the board of directors accepted the resignations of Timothy Rogers as Chief Executive Officer and Seamus McAuley as Chief Commercial Officer.

Also on June 21, 2021, we have appointed the following officers and directors: Tim Rogers as the Chairman of the Board, Colin Stott as Chief Operating Officer and Director, and Seamus McAuley as Chief Executive Officer.

Timothy Paul Rogers - Director /Chairman - Age 57

The employment history for Mr. Rogers is contained in Form 10-KT filed with the SEC on June 9, 2021.

Seamus McAuley - Chief Executive Officer- Age 45

The employment history for Mr. McAuley is contained in Form 10-KT filed with the SEC on June 9, 2021.

Colin Stott - Chief Operating Officer and Director - Age 54

From November 2020 - present, Mr. Stott has been Founder and Chief Executive Officer of Phytotherapeutix Holdings Ltd. From April 2019 - present, Mr. Stott has been Founder and Chief Executive Officer of Phytotherapeutix Ltd. From July 1, 2019 - December 1, 2020, he served as Chief Operating Officer for Alinova Biosciences Ltd. From June 1, 2017 - May 31, 2019, he served as Scientific Affairs Director, International Division for GW Pharmaceuticals plc. From January 2001 - May 31, 2017, he was R & D Operations Director for GW Pharmaceuticals plc.

Aside from the following, none of our new officers has had any material direct or indirect interest in any of our transactions or proposed transactions over the last two years. On January 19, 2021, we entered into a Stock Purchase Agreement with ABTI Pharma Limited, a company registered in England and Wales ("ABTI Pharma"), pursuant to which we acquired all of the outstanding shares of capital stock of ABTI Pharma from its shareholders in exchange for 600,000,000 shares of our company pro rata to the ABTI Pharma shareholders.

Also, we plan to enter into employment agreements with our executive officers once we raised sufficient capital to meet the financial obligations under those agreements.

There are no family relationships between any of the foregoing appointees and any of our directors or executive officers.

2

© Edgar Online, source Glimpses

All news about ALTEROLA BIOTECH, INC.
08/19ALTEROLA BIOTECH : Management's Discussion and Analysis of Financial Condition a..
AQ
08/02ALTEROLA BIOTECH : acquires ABTI pharma ltd
AQ
06/21ALTEROLA BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)
AQ
06/16ALTEROLA BIOTECH INC. : Entry into a Material Definitive Agreement, Completion o..
AQ
06/16ABTI Pharma Limited completed the acquisition of Alterola Biotech, Inc. in re..
CI
06/09ALTEROLA BIOTECH : 10-KT - Management's Discussion and Analysis of Financial Con..
AQ
06/09Alterola Biotech, Inc. Reports Earnings Results for the Half Year Ended March..
CI
06/09ALTEROLA BIOTECH INC. : Amendments to Articles of Inc. or Bylaws; Change in Fisc..
AQ
05/28ALTEROLA BIOTECH : Management's Discussion and Analysis of Financial Condition a..
AQ
05/25ALTEROLA BIOTECH INC. : Entry into a Material Definitive Agreement, Financial St..
AQ
More news
Chart ALTEROLA BIOTECH, INC.
Duration : Period :
Alterola Biotech, Inc. Technical Analysis Chart | ABTI | US02152V1035 | MarketScreener
Managers and Directors
Seamus McAuley Chief Executive Officer
Larson Elmore Vice Chairman, CFO, Secretary & CAO
Timothy Paul Rogers Chairman
Colin Stott Chief Operating Officer & Director
Dominic Schiller Director
Sector and Competitors
1st jan.Capi. (M$)
ALTEROLA BIOTECH, INC.0.00%950
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
REGENERON PHARMACEUTICALS34.93%67 775
WUXI APPTEC CO., LTD.35.75%60 418
VERTEX PHARMACEUTICALS-20.33%48 850